CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses
Research and development	$ 34,300	$ 12,000
General and administrative	7,455	3,342
Total operating expenses	41,788	15,374
Loss from operations	(41,788)	(15,374)
Other income
Interest income	5,014	2,867
Total other income	5,014	2,867
Net loss before income taxes	(36,774)	(12,507)
Income tax expense	(72)	(1)
Net loss	$ (36,846)	$ (12,508)
Net Loss per share, basic (in usd per share)	$ (0.68)	$ (18.94)
Net Loss per share, diluted (in usd per share)	$ (0.68)	$ (18.94)
Weighted-average number common shares outstanding, basic (in shares)	54,456,515	660,288
Weighted-average number common shares outstanding, diluted (in shares)	54,456,515	660,288
Related Party
Operating expenses
Research and development	$ 6,575	$ 3,581
Nonrelated Party
Operating expenses
Research and development	$ 27,758	$ 8,451